RecallDepth

EZ Breathe Medication Cup. For the delivery of liquid medications for respiratory usage.

This recall has been terminated (originally issued May 29, 2013).

Company
Nephron Pharmaceuticals Corp.
Recall Initiated
April 30, 2013
Posted
May 29, 2013
Terminated
June 28, 2016
Recall Number
Z-1373-2013
Quantity
750 Medications Cups
Firm Location
Orlando, FL
Official Source
View on FDA website ↗

Reason for Recall

Possible dislodgement of the "Plate A", if this instance occurs, it presents a potential choking hazard.

Distribution

Worldwide Distribution-USA (nationwide) including DC and Puerto Rico and the states of AL, AZ, CA, CO, CT, FL, IL, IN, IO, GA, KS, KY, LA, MD, MN, MS, MO, NK, NV, NJ, NM, NY, OH, OK, OR, PA, RI, SC, TN , TX, VT, VA, WA, and WV, and the countries of Guatemala, Poland, Panama, and United Kingdom.

Lot / Code Info

Lots #120902, Lot # 120903 and Lot # 120904

Root Cause

Nonconforming Material/Component

Action Taken

The firm, Nephron Pharmaceuticals Corporation, notified its consignees on April 30, 2013, and May 3, 2013, of the problem via a recall notice and a Press Release, respectively. The firm directed consignees to discontinue use of any EZ Breathe atomizer units contained in the Asthmanefrin Starter Kits with the affected lot numbers and also those that were sold individually. Customers were directed to return all affected product.

More recalls by Nephron Pharmaceuticals Corp.

View all recalls by this company →